Analysis and Commentary 2/7/20 Analysis and Commentary 2/7/20 Shuren Fills Alliance in on Fast-Moving Science and CDRH Needs Read More 7/24/18 7/24/18 “First, do no harm” Read More Advocacy at a Glance 7/13/18 Advocacy at a Glance 7/13/18 Timing of Ag/FDA Appropriations Bills Still TBD Read More Advocacy at a Glance 5/4/18 Advocacy at a Glance 5/4/18 Congress Returns May 7; Starts 11-Week Sprint to August Recess and more Read More Advocacy at a Glance 9/23/17 Advocacy at a Glance 9/23/17 Where We're at Now and What's Coming Next Read More Advocacy at a Glance 9/1/17 Advocacy at a Glance 9/1/17 A Busy and Consequential Month for Congress and more Read More Analysis and Commentary 7/21/17 Analysis and Commentary 7/21/17 Level Funding for FY 18 Will NOT Allow FDA to Meet All Current Needs Read More Analysis and Commentary 4/22/16 Analysis and Commentary 4/22/16 The Start of the Califf Era Read More
Analysis and Commentary 2/7/20 Analysis and Commentary 2/7/20 Shuren Fills Alliance in on Fast-Moving Science and CDRH Needs Read More
Advocacy at a Glance 7/13/18 Advocacy at a Glance 7/13/18 Timing of Ag/FDA Appropriations Bills Still TBD Read More
Advocacy at a Glance 5/4/18 Advocacy at a Glance 5/4/18 Congress Returns May 7; Starts 11-Week Sprint to August Recess and more Read More
Advocacy at a Glance 9/23/17 Advocacy at a Glance 9/23/17 Where We're at Now and What's Coming Next Read More
Advocacy at a Glance 9/1/17 Advocacy at a Glance 9/1/17 A Busy and Consequential Month for Congress and more Read More
Analysis and Commentary 7/21/17 Analysis and Commentary 7/21/17 Level Funding for FY 18 Will NOT Allow FDA to Meet All Current Needs Read More
Analysis and Commentary 4/22/16 Analysis and Commentary 4/22/16 The Start of the Califf Era Read More
